Insider Selling: Tenet Healthcare (NYSE:THC) Director Sells $2,634,200.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Richard Mark sold 10,000 shares of the stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the sale, the director owned 25,121 shares in the company, valued at $6,617,373.82. The trade was a 28.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Tenet Healthcare Stock Up 1.8%

NYSE THC opened at $265.56 on Thursday. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $283.05. The firm has a market capitalization of $21.38 billion, a price-to-earnings ratio of 10.24, a PEG ratio of 0.99 and a beta of 1.23. The company has a fifty day moving average of $248.41 and a two-hundred day moving average of $212.79.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, analysts predict that Tenet Healthcare Corporation will post 21.04 earnings per share for the current year.

Institutional Trading of Tenet Healthcare

Hedge funds have recently added to or reduced their stakes in the business. Elyxium Wealth LLC purchased a new position in Tenet Healthcare during the 4th quarter valued at about $29,000. Trust Co. of Vermont bought a new position in shares of Tenet Healthcare during the second quarter valued at approximately $37,000. OP Asset Management Ltd purchased a new position in Tenet Healthcare during the first quarter valued at approximately $49,000. Compass Financial Management LLC bought a new position in Tenet Healthcare in the second quarter worth approximately $57,000. Finally, William B. Walkup & Associates Inc. boosted its position in Tenet Healthcare by 88.7% during the 4th quarter. William B. Walkup & Associates Inc. now owns 302 shares of the company’s stock valued at $60,000 after acquiring an additional 142 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

THC has been the subject of a number of research analyst reports. Truist Financial raised their price target on Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Royal Bank Of Canada boosted their target price on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research note on Monday, July 27th. Robert W. Baird upped their price target on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a report on Tuesday, July 28th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $305.00 price objective on shares of Tenet Healthcare in a report on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $275.53.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Strong analyst and quantitative support: Zacks highlighted Tenet among hospital operators benefiting from steady healthcare demand and improved efficiency. THC was also added to Zacks’ Rank #1 “Strong Buy” lists for both growth and value stocks, reinforcing the view that its earnings outlook and valuation remain attractive. 3 Hospital Stocks Riding Strong Demand and Improved Efficiency Best Growth Stocks to Buy for September 16th Best Value Stocks to Buy for September 16th
• Positive Sentiment: Potential undervaluation and earnings momentum: Zacks’ latest analysis points to favorable value, growth and momentum characteristics. That view is supported by Tenet’s latest quarterly results, which exceeded earnings and revenue estimates, with revenue increasing year over year. Are Investors Undervaluing Tenet Healthcare
• Positive Sentiment: Ambulatory strategy remains a strength: Coverage of United Surgical Partners International, Tenet’s ambulatory surgery platform, keeps attention on outpatient care, an area that can support more efficient growth and portfolio optimization. Tenet’s full-year 2026 EPS guidance and predominantly positive analyst ratings also support the bullish case. 5 Things to Know About United Surgical Partners International
• Neutral Sentiment: Restructuring creates mixed implications: Tenet’s $2.7 billion Conifer breakup is reportedly leading to 1,037 job cuts. The separation could streamline operations and sharpen strategic focus, but the near-term workforce reduction highlights execution and restructuring risks. Tenet’s $2.7B Conifer Breakup Triggers 1,037 Job Cuts
• Negative Sentiment: Director stock sale: Director Richard Mark sold 10,000 THC shares for approximately $2.6 million, reducing his position by 28.47%. The transaction is relatively small compared with Tenet’s market value but may weigh modestly on sentiment because it represents insider selling. Richard Mark Sells 10,000 Shares of Tenet Healthcare

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company that owns and operates acute care hospitals and other healthcare facilities in the United States. Its hospitals provide services including emergency care, surgery, cardiovascular care, orthopedics, oncology, women’s health and other inpatient and outpatient treatments.

Through its ambulatory business, United Surgical Partners International, Tenet operates and manages ambulatory surgery centers and other outpatient facilities.